ACM
RMD icon

AlphaCrest Capital Management’s ResMed RMD Stock Holding History

AlphaCrest Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,353
Closed -$1.82M – 917
2022
Q3 		$1.82M Sell
8,353
-3,776
-31% -$859K 0.11% 263
2022
Q2 		$2.54M Sell
12,129
-2,164
-15% -$461K 0.12% 219
2022
Q1 		$3.47M Sell
14,293
-10,405
-42% -$2.52M 0.19% 95
2021
Q4 		$6.43M Buy
24,698
+12,888
+109% +$3.34M 0.24% 61
2021
Q3 		$3.11M Buy
11,810
+10,874
+1,162% +$2.97M 0.16% 146
2021
Q2 		$231K Sell
936
-30,603
-97% -$6.43M 0.01% 1172
2021
Q1 		$6.12M Buy
31,539
+26,291
+501% +$5.27M 0.34% 45
2020
Q4 		$1.12M Sell
5,248
-3,549
-40% -$708K 0.09% 282
2020
Q3 		$1.51M Buy
8,797
+7,152
+435% +$1.32M 0.16% 147
2020
Q2 		$316K Sell
1,645
-6,875
-81% -$1.12M 0.05% 606
2020
Q1 		$1.25M Buy
8,520
+4,224
+98% +$673K 0.15% 190
2019
Q4 		$666K Sell
4,296
-1,937
-31% -$279K 0.05% 596
2019
Q3 		$842K Buy
+6,233
New +$817K 0.05% 664
2019
Q2 		– Sell
-2,743
Closed -$285K – 1121
2019
Q1 		$285K Buy
+2,743
New +$283K 0.04% 670

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

AlphaCrest Capital Management's RMD Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of ResMed (RMD) in Q4 2022, closing a stake of 8,353 shares — an estimated $1.82M sold.

AlphaCrest Capital Management first reported a position in RMD in Q1 2019 and held it in 14 quarters. The position peaked at $6.43M in Q4 2021. 732 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining ResMed position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 8,353 ResMed shares in Q4 2022, an estimated $1.82M.
  • AlphaCrest Capital Management first reported a position in ResMed in Q1 2019 and held it in 14 quarters.
  • AlphaCrest Capital Management's ResMed position peaked at $6.43M in Q4 2021.
  • 732 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.